Skip to main content
SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD logo

SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000078 ISIN · CNE000000X95 LEI · 300300J4GCOV7CYQTB51 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,614 across all filing types
Latest filing 2025-10-24 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 000078

About SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD

https://www.neptunusbio.com

Shenzhen Neptunus Bioengineering Co., Ltd. is a comprehensive healthcare enterprise focused on the research, development, manufacturing, and distribution of pharmaceutical products. The company operates across the entire industry value chain, including the production of chemical drugs, biological preparations, and traditional Chinese medicines. Its portfolio extends to medical devices and health supplements. A significant component of its operations involves a large-scale pharmaceutical distribution network and a nationwide retail pharmacy chain. The company emphasizes innovation in biotechnology and maintains modern production facilities to support its diverse product lines. By integrating R&D with a robust logistics and retail infrastructure, it provides a wide range of healthcare solutions to medical institutions and consumers.

Recent filings

Filing Released Lang Actions
2025年第二次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the 2025 second extraordinary shareholders' meeting of Shenzhen Haiwang Bioengineering Co., Ltd. It includes voting results on various proposals such as election of board members, amendments to company articles, and other corporate governance matters. The document contains specific vote counts and percentages, meeting details, and legal opinions confirming the validity of the meeting and resolutions. This type of document is a formal announcement of voting results from a shareholders' meeting, which fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). It is not a full annual or interim report, nor a management or audit report, but specifically the official voting results announcement.
2025-10-24 Chinese
第十届董事局第二次会议决议公告
Board/Management Information Classification · 100% confidence The document is an announcement of resolutions passed at a board of directors meeting, including appointments of the company president, financial director, board secretary, vice presidents, and securities affairs representative. It details voting results and references compliance with company law and articles of association. There is no financial data, earnings information, or regulatory filings beyond board/management changes. The content clearly fits the category of Board/Management Information (MANG). The document length is short and focused solely on management appointments, not a full report or announcement of a report publication.
2025-10-24 Chinese
募集资金管理制度（2025年10月）
Capital/Financing Update Classification · 95% confidence The document is titled "深圳市海王生物工程股份有限公司 募集资金管理制度" which translates to "Shenzhen Haier Bioengineering Co., Ltd. Fundraising Capital Management System." It is a detailed internal policy document outlining the management, use, supervision, and regulatory compliance related to the company's fundraising capital. The content includes rules on the use of raised funds, storage in special accounts, supervision by the board and auditors, and procedures for changes in fund usage. There is no indication that this is a financial report, earnings release, or announcement of voting results. It is not a report publication announcement since it is a substantive internal policy document exceeding 5,000 characters. It is not a regulatory filing or certification letter. The document is a governance-related internal control and compliance policy concerning capital raised by the company. Therefore, the most appropriate classification is "Capital/Financing Update (CAP)" as it deals with the management and use of capital raised by the company, which fits the description of updates on company fundraising and capital structure changes.
2025-10-24 Chinese
关联交易管理制度（2025年10月）
Governance Information Classification · 95% confidence The document is titled '关联交易管理制度' which translates to 'Related Party Transaction Management System'. It outlines the principles, scope, procedures, and responsibilities related to related party transactions within the company. The content is regulatory and governance-focused, detailing internal rules and compliance with laws and stock exchange regulations. It does not contain financial statements, earnings data, or audit results. It is not an announcement or a brief notice but a detailed governance document. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-10-24 Chinese
会计师事务所选聘制度（2025年10月）
Governance Information Classification · 95% confidence The document is titled '会计师事务所选聘制度' which translates to 'Accounting Firm Selection System' and details the procedures, requirements, and governance for selecting and appointing the company's external auditors. It references relevant laws and regulations, outlines the roles of the audit committee, board, and shareholders in approving the appointment, and includes provisions for reappointment and replacement of auditors. There are no financial statements, audit results, or report data included. The document is a governance and procedural policy related to audit firm selection rather than an audit report or annual report itself. Therefore, it fits best under Governance Information (CGR), which covers internal rules and governance practices related to board and audit functions.
2025-10-24 Chinese
独立董事提名人声明与承诺（张巍松）
Board/Management Information Classification · 95% confidence The document is a formal statement and commitment regarding the nomination of an independent director candidate for the company's board. It details qualifications, compliance with laws and regulations, and declarations of independence. There are no financial statements, earnings data, or report attachments. The content is focused on board/management information, specifically about a director nomination. The document length is 3270 characters, which is relatively short and does not contain financial data or report publication language. Therefore, it fits best under Board/Management Information (MANG).
2025-09-29 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.